Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection. | Front Med (Lausanne) | 2021 | 34901094 | PubTator, text mining | PubMed |
| Importance of Bile Composition for Diagnosis of Biliary Obstructions. | Molecules | 2021 | 34885858 | PubTator, text mining | PubMed |
| Substrate-Dependent Trans-Stimulation of Organic Cation Transporter 2 Activity. | Int J Mol Sci | 2021 | 34884730 | PubTator, text mining | PubMed |
| Physiologically Based Modeling of the Effect of Physiological and Anthropometric Variability on Indocyanine Green Based Liver Function Tests. | Front Physiol | 2021 | 34880776 | PubTator, text mining | PubMed |
| Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic. | World J Gastroenterol | 2021 | 34876788 | PubTator, text mining | PubMed |
| Degree of reduction in normal liver complication probability from free-breathing to breath-hold liver SBRT: a dose-escalation strategy using radiation dose-volume effect. | Biomed Phys Eng Express | 2021 | 34874286 | PubTator, text mining | PubMed |
| Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis. | United European Gastroenterol J | 2021 | 34873866 | PubTator, text mining | PubMed |
| Host directed therapies: COVID-19 and beyond. | Curr Res Pharmacol Drug Discov | 2021 | 34870156 | PubTator, text mining | PubMed |
| Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature. | Front Pharmacol | 2021 | 34867341 | PubTator, text mining | PubMed |
| Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells. | Stem Cell Reports | 2021 | 34861164 | PubTator, text mining | PubMed |
| Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis. | Drug Deliv | 2021 | 34854788 | PubTator, text mining | PubMed |
| Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection. | Mol Ther Methods Clin Dev | 2021 | 34853804 | PubTator, text mining | PubMed |
| A nuanced role of the small loop of hepatitis B virus small envelope protein in virion morphogenesis and secretion. | J Biomed Sci | 2021 | 34852809 | PubTator, text mining | PubMed |
| Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant. | Viruses | 2021 | 34835134 | PubTator, text mining | PubMed |
| In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors. | Viruses | 2021 | 34835053 | PubTator, text mining | PubMed |
| Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity. | Cells | 2021 | 34831475 | PubTator, text mining | PubMed |
| Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease. | Cells | 2021 | 34831031 | PubTator, text mining | PubMed |
| The Hepatitis B Virus Nucleocapsid-Dynamic Compartment for Infectious Virus Production and New Antiviral Target. | Biomedicines | 2021 | 34829806 | PubTator, text mining | PubMed |
| Bioactivity of Dietary Polyphenols: The Role in LDL-C Lowering. | Foods | 2021 | 34828946 | PubTator, text mining | PubMed |
| NLRX1 can counteract innate immune response induced by an external stimulus favoring HBV infection by competitive inhibition of MAVS-RLRs signaling in HepG2-NTCP cells. | Sci Prog | 2021 | 34825857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=51